CEO Hoess and CMO Harstrick hold a conference call highlighting clinical data for Acimtamig (AFM13) and AFM24 on December 11 at 4:30 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AFMD:
- Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
- Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24
- Affimed price target lowered to $3 from $4 at Wells Fargo
- Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
- Affimed reports Q3 EPS (EUR0.16) vs. (EUR0.11) last year